IDO1 and neoplasm: Studies performed on head and neck cancer biopsies utilizing the spatial architecture of the tumor have identified markers such as PD-L1, PD-1, STING, IDO1, GZMB, and Ki67 to be differentially expressed between different locations of the tumor and being predictive of progressive disease (17).